FDA Issues Warning Letters to Companies Illegally Selling CBD and Delta-8 THC Products
May 4, 2022
Today, the U.S. Food and Drug Administration issued warning letters to five companies for selling products labeled as containing delta-8 tetrahydrocannabinol (delta-8 THC) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action is the first time the FDA has issued warning letters for products containing delta-8 THC. Delta-8 THC has psychoactive and intoxicating effects and may be dangerous to consumers. The FDA has received reports of adverse events experienced by patients who have consumed these products.
![](https://cdn.prod.website-files.com/65c91aa1879f622b3cc077c7/65c91c166f3eeed67092aa34_quotemarks.jpg)
—
Facilitation
•
Data-Informed Practice
•
Metrics to Guide Community-Level Prevention